Literature DB >> 16322957

Heartburn issues burnt out?

Kentaro Sugano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322957     DOI: 10.1007/s00535-005-1703-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


× No keyword cloud information.
  19 in total

1.  Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?

Authors:  T Soga; M Matsuura; Y Kodama; T Fujita; I Sekimoto; K Nishimura; S Yoshida; H Kutsumi; S Fujimoto
Journal:  J Gastroenterol       Date:  1999-08       Impact factor: 7.527

2.  The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population.

Authors:  T Murai; H Miwa; R Ohkura; R Iwazaki; A Nagahara; K Sato; T Yamada; K Ota; H Tanaka; M Kawabe; T Minowa; Y Takei; A Miyazaki; N Sato
Journal:  Aliment Pharmacol Ther       Date:  2000-04       Impact factor: 8.171

3.  High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis.

Authors:  H Hamada; K Haruma; M Mihara; T Kamada; M Yoshihara; K Sumii; G Kajiyama; M Kawanishi
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

4.  Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring.

Authors:  K Haruma; M Mihara; E Okamoto; H Kusunoki; M Hananoki; S Tanaka; M Yoshihara; K Sumii; G Kajiyama
Journal:  Aliment Pharmacol Ther       Date:  1999-02       Impact factor: 8.171

5.  Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication.

Authors:  K Iijima; S Ohara; H Sekine; T Koike; K Kato; S Asaki; T Shimosegawa; T Toyota
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

6.  Helicobacter pylori eradication induces marked increase in H+/K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa.

Authors:  H Osawa; H Kita; H Ohnishi; H Hoshino; H Mutoh; Y Ishino; E Watanabe; K Satoh; K Sugano
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

7.  Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease.

Authors:  R Befrits; S Sjöstedt; B Odman; H Sörngård; G Lindberg
Journal:  Helicobacter       Date:  2000-12       Impact factor: 5.753

8.  Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Authors:  E J Kuipers; G F Nelis; E C Klinkenberg-Knol; P Snel; D Goldfain; J J Kolkman; H P M Festen; J Dent; P Zeitoun; N Havu; M Lamm; A Walan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Helicobacter pylori infection prevents the occurrence of the tolerance phenomenon of histamine H2 receptor antagonists.

Authors:  T Fujisawa; K Adachi; Y Komazawa; T Mihara; T Azumi; T Katsube; K Furuta; H Kazumori; Y Kinoshita
Journal:  Aliment Pharmacol Ther       Date:  2004-09-01       Impact factor: 8.171

10.  Development of reflux esophagitis following Helicobacter pylori eradication.

Authors:  Masahiro Kawanishi
Journal:  J Gastroenterol       Date:  2005-11       Impact factor: 6.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.